Jay A. Rosenberg

发表论文 42 篇 · 总被引 5298 次 · h-index 17

代表论文

• Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma (1994 · Blood · 被引 756)
• Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment (2000 · Journal of Clinical Oncology · 被引 690)
• IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. (1997 · Journal of Clinical Oncology · 被引 644)
• Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma (1998 · Annals of Oncology · 被引 526)
• Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity (2001 · Journal of Clinical Oncology · 被引 511)
• Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment (2002 · Blood · 被引 425)